Brainscape's Knowledge GenomeTM


Top Flashcards (Certified)
All Flashcards

Med > Psych > Flashcards

Psych Flashcards

1
Q

Admissin for suicide if

A 
Plan+
Intention to act on the plan
Access to lethal means
Recent social stressors
Symptoms of a psychiatric disorder
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

SGA in refractory schizo

A

Clozapine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Route of antipsychotic administration in severe cases of schizo

A

IM q 2-4 wk

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

If schizo with aggression/impulsiveness

A

Mood stabilizer (Li, valp, carba)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Duration of treatment of schizo

A

At least 1-2 y after the 1st episode

At least 5 y after multiple episodes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

If schizo with anxiety

A

Add anxiolytics

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Schizophreniform

A

Symptoms for 1-6 mo

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Schizoaffective Tx

A

Antipsychotics
Mood stabilizers
(Antidepressants)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Not to be prescribed in acute psychosis and mania

A

Antidepressants

Stimulants

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Delusional disorder Tx

A

Psychotherapy
Antipsychotics
Antidepressants

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

W/U for mood disorders

A

CBC, TFT, extended lytes, U/A, drug screen
PEx, DHx
+/- CXR, ECG, CT head, neuro consult

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Duration of criterion A for schizo

A

1 mo

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Duration of pure psychosis in schizoaffective

A

2 wk

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Duration of criterion A for MDE

A

2 wk

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Duration of criterion A for manic episode

A

1 wk

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Duration of delusion for delusional disorder

A

1 mo

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Disorganized speech in schyzo

A

Derailment

Incoherence

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Speech in mania

A

Flight if idea

Subjective: thoughts are racing

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Hypomanic episode

A

Change in function is present, but no marked impairment in function

No psychosis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Clinical importance of mixed features in bipolar or depression

A

Increased risk of suicide

If found in pts with MDD, high index of suspicion for bipolar disorder

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

Symptom-free interval between depressed episodes for Dx of recurrent depression

A

2 mo

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

Parent loss before this age is a RF for depression

A

11 y/o

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

Supplement for depression

A

Zinc

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

1st line in depression Tx

A

Sertraline
Escitalopram
Venlafaxin
Mirtazapine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Typical response to anti-depressants
Physical symptoms in 2 wk | Mood/cognition by 4 wk
26
No/partial response to anti-depressants after 3-4 wk
Optimize dose
27
No response to dose optimization after 4-8 wk
Switch
28
Partial response after dose optimization of anti-depressant
Combine or augment
29
Fastest and most effective treatment for MDD
ECT
30
Persistent depressive disorder
2 y or more in adults | 1 y or more in children/adolescence
31
St. John’s Wort
Tx of MDD
32
Postpartum blues
Begins 2-4 d postpartum Lasts 48 h (up to 10 d) No Tx Prevalence 50-80%
33
MDD with peripartum onset
``` Prevalence 10% Onset during pregnancy or within 4 wk following delivery Lasts 2-6 mo Residual symptoms can last up to 1 y +/- psychosis +/- mania ```
34
Tx of peripartum MDD
CBT, IPT SSRI ECT
35
Risk of suicide in bipolar
Greatest when switching from mania to depression
36
1st line in treating BPII depression
Quetiapine
37
Treating mania
``` Li Valp Carba (2nd line) SGA ECT Benzodiazepines ( if acute agitation) ```
38
Preventing mania
Li Valp Carba SGA (Lower dosages)
39
Treating depression of BP
``` Li Lurasidone Lamotr Quetiapine Antidepressant(plus mood stabilizer) ECT ```
40
Preventing depression in BP
``` Li Lurasidone Quetiapine Lamotrigine Aripiprazole Valp ```
41
Mixed episode, Rapid cycling Tx
Li/valp | +SGA (lurasidone, aripiprazole, olanzapune)
42
Rapid cycling BP
4+ mood episodes in 1 y
43
Cyclothymia
Numerous episodes of hypomanic/depressive symptoms for 2 y or more. Not meeting full hypomania or MDE criteria
44
Tx of cyclothymia
Mood stabilizer +/- psychotherapy
45
Proven effect in preventing suicide in BP
Li
46
Vitamin deficiency mimicking anxiety
B12
47
Routine screening for anxiety
CBC, TFT, lytes, U/A, urine drug screen | +/- ECG, CXR, CT head, neuro consult
48
Duration of anxiety about panic attack
1 mo or more
49
Panic disorder Tx
CBT | SSRI/SNRI ( start low, go slow, aim high)
50
Duration of Tx for panic disorder
12 wk to see full response | Treat for up to 1 y after symptoms resolve
51
Drugs to avoid in panic disorder
Bupropion | TCA
52
Duration for agoraphobia Dx
6 mo or more
53
Duration for GAD Dx
6 mo or more
54
Lifestyle changes for GAD
Caffeine avoidance EtOH avoidance Sleep hygiene
55
Lifestyle changes for BP
Psychoeducation Regular check ins Emergency plan Stable routine (sleep, meal, exercise)
56
Lifestyle changes for MDD
Aerobic exercise Mindfulness Zinc
57
GAD Tx
CBT (relaxation technics, mindfulness) SSRI, SNRI (1st line) +/- benzod
58
2nd line for GAD
Buspirone | Bupropion
59
Not recommended for GAD
BBlocker
60
Phobia duration for Dx
6 mo or more
61
Phobia Tx
CBT (exposure therapy, gradually facing feared situations) SSRI/SNRI MAOI BB/benzod in acute situations
62
More efficacious Tx for phobic disorders
Behavioral therapy
63
OCD Tx
CBT (exposure with response prevention, challenging underlying beliefs) SSRI/SNRI (12-16 wk) Clomipeamine +/- antipsychotics
64
Duration for PTSD Dx
1 mo
65
PTSD Tx
CBT ( emotional regulation techniques, then explore/mourn trauma, challenge dysfunctional beliefs, exposure therapy) SSRI Prazocin (nightmares) Benzod (acute anxiety) +/- SGA Eye movement desensitization and reprocessing
66
Adjustment disorder timing
Starts within 3 mo of the onset of the stressor | Ends within 6 mo of the termination of the stressor
67
Adjustment disorder Tx
Brief psychotherapy | Benzod (significant anxiety)
68
Bereavement Tx
Support Watchful waiting Education and normalization of the grief process
69
Grief therapy indications
Those who need additional support Complex grief/bereavement Significant MDD
70
Indications of pharmacotherapy in bereavement
MDD present PHx of mood disorders Severe/autonomous symptoms
71
The most common persistent symptom in normal grief
Lonliness
72
Delirium w/u
CBC,diff, extended lytes, BUN, Cr, LFT, TFT, U/A, urine S/C, B12, folate, B1, Alb, glucose +/- ECG, CXR, CT head, EEG, toxicology/heavy metal, VDRL, HIV, LP, B/C
73
AB causing delirium
Quinolons
74
CT head in delirium if:
``` Focal signs Hx of cancer Anticoagulant use Acute change in status Gait change Acute incontinence ```
75
MRI indications for delirium:
If suspicion of acute/subacute stroke Multifocal inflammatory lesions And negative CT
76
Delirium pharmacologic Tx
Halopridol Risperidone Olanzapune (sedating, less QT prolingation) Quetiapine (if EPS) Aripiprazole (may shorten QTc) Benzod (for alcohol/subs withdrawal delirium)
77
Cognitive domains
``` Learning and language Memory Executive Perceptual-motor Complex attention Social cognition ```
78
4As of dementia
Amnesia Aphasia Agnosia Apraxia
79
Mini Cog rapid assessment
3 word immediate recall Clock drawn to 10 past 11 3 word delayed recall
80
Alzheimer’s disease main problem
Learning and memory
81
Frontotemporal degeneration
Language type | Behavioral type
82
Lewy body disease
``` Visual hallucination EPS Autonomic impairment Fluctuating No well response to pharmacotherapy ```
83
Vascular dementia
Vascular RFs Focal neurological signs Abrupt onset Stepwise progression
84
Normal pressure hydrocephalus
Abnormal gait Early incontinence Rapid progression
85
Investigation for dementia
CBC, diff, extended lytes, BUN, Cr, LFT, TFT, U/A, Urine C/S, B12, folate, Alb, Glucose +/- VDRL, HIV, SPECT, CT head
86
CT head indications in dementia
``` Focal signs Anticoagulant Hx of cancer Gait problem Acute change in status Acute incontinence Age younger than 60 Rapid onset Duration less than 2 y Recent significant head trauma Unexpected neurological symptoms ```
87
Dementia management
Cholinesterase inhibitors (mild-mod) NMDA receptor anta (mod-sev) low-dose neuroleptics (behavioral symptoms) Antidepressants/trazodone (emotional symptoms) Reassess q 3 mo
88
Rivastigmine
Cholinesterase inhibitor
89
Donepezil
Cholinesterase inhibitor
90
Galantamine
Cholinesterase inhibitor
91
Memantine
NMDA rec anta
92
Sleep in dementia
Fragmented at night
93
Sleep in delirium
Reversed sleep wake cycle
94
Sleep in depression
Early morning awakening Reduced Rem latency Increased REM reduced slow wave sleep
95
Speech in dementia
Echolalia | Palilalia
96
Hallmark of substance abuse
Dependence
97
The class of substances without withdrawal effect
Hallucinogens
98
1st thing to consider when approaching a pt with substance abuse
Pt’s current state of change
99
Legal limit of alcohol level for impaired driving
10.6 mmol/L | 50 mg/dL
100
Reaching legal limit of alcohol for impaired driving in men and women
Men: 2-3 drinks/h Women: 1-2 drinks/h
101
Coma with alcohol
>60 mmol/L (non-tolerant) | >90-120 mmol/L (tolerant)
102
Alcohol withdrawal time
12-48 h after prolonged drinking
103
Delirium tremes timing
3-5 d
104
Alcohol withdrawal Tx
Diazepam PO Thiamine IM then PO Supportive
105
Lorazepam instead of diazepam for alcohol withdrawal if:
Age>65 Severe liver disease Severe asthma Respiratory failure
106
If hallucination in alcohol withdrawal
Halopridol (+ diazepam) | Or SGA
107
Admission for alcohol withdrawal if
``` Still in withdrawal after 80 mg diazepam Delirium (tremens) Arrhythmia (recurrent) Seizure (multiple) Medically ill Unsafe to discharge ```
108
Wernicke encephalopathy
Oculomotor dysfunction (nystagmus, CN VI palsy) Gait ataxia Confusion
109
Wernicke Tx
Thiamine 100 PO OD x 1-2 wk
110
Korsakoff’s syndrom
Anterograde amnesia Confabulation Persists beyond duration of intixication/withdrawal
111
Korsakoff Tx
Thiamine 100 PO bid/tid x 3-12 mo
112
Tx of alcohol use diorder
Naltrexone Disulfiram (for abstinence) Acampeoste (maintain abstinence)
113
Opioid overdose management
ABC Glucose Naloxone (drip until alert w/o it up to > 48 h) Observe at least 24 h
114
Onset of opioid withdrawal
6-12 h
115
Duration of opioid withdrawal
5-10
116
Opioid withdrawal management
Methadone Buprenorphine Clonidine ( a adrenergic agonist)
117
Opioid use disorder Tx
Methadone Buprenorphine Suboxone (naloxone + buprenorphine) SL route
118
Cocaine overdose in ECG
Prolongation of QRS
119
Cocaine overdose Tx
Diazepam for seizures
120
Not recommended for cocaine overdose
BB
121
Cocaine withdrawal timing
Initial crash 1-48 h | Withdrawal 1-10 wk
122
Cocaine withdrawal Tx
Supportive
123
Cocaine use disorder Tx
None
124
Diseases with cocaine
``` CTD Paranoia Psychosis Delirium Suicide CVD Seizures ```
125
Diseases by amphetamines
``` Psychotic mania (high doses) Paranoid psychosis (chronic use) ```
126
Amphetamine overdose Tx
Psychosis: antipsychotic Agitation: benzod Tachycardia, HTN: BB
127
Diseases by cannabis
``` Paranoia (high dose) Psychosis (high dose) Schizophrenia (high dose) Depersonalization, anxiety (high dose) Manic episodes (chronic use) Apathetic, amotivational state (chronic use) ```
128
Screen for cannabis
Urine
129
Cannabinoid hyperemesis syndrome Tx
Hot baths/ showers
130
Rapid tolerance No physical dependency No specific withdrawal
Hallucinogens
131
Tx of Acute intoxication with hallucinogens
Supportive Reassurance Decrease stimulation Benzod/antipsychotic seldom required
132
Diseases by hallucinogens
Psychosis | Mood disorders
133
Jaw clenching
Ecstasy | GHB
134
DIC
Ecstasy
135
Rhabdomyolysis
Ecstasy
136
Dissociative state
Ketamin
137
Hallucinogen with amnestic and analgesic effect
Ketamin
138
Catatonia in overdose with
Ketamin
139
Appetite increasing substance
Cannabis
140
Formication
Metamphetamine
141
Acute lead poisoning
Metamphetamine
142
Nystagmus (horizontal/vertical)
PCP
143
Myoclonus
PCP
144
Date rape drugs
GHB Flunitrazepam Ketamin
145
Hallucinogen for PTSD
Ecstasy
146
Hallucinogen for rapid treatment of depression
Ketamin
147
Hallucinogens for end of life anxiety
LSD | psilocybin
148
Hallucinogen for treatment of addiction
Ibogaine
149
Somatic syndrome disorder duration
>6 mo
150
Duration of illness anxiety disorder
6 mo or more
151
Somatic symptom Tx
``` Psychotherapy Brief regular visits Necessary investigations Limit number of involved physicians Minimize medical investigations Anxiolytic (short term) Antidepressants (if depression or anxiety) ```
152
La belle indifférence
Conversion disorder
153
Tx of paraphilia
Anti androgen Behavior modification Psychotherapy
154
Tx of gender dysphoria
Psychotherapy Hormonal therapy Surgery
155
Personalities susceptible to eating disorders
OCD histrionic Borderline
156
Familial psychiatric disorder prevalent in bulimia nervosa
Affective disorders
157
RF for bulimia
Sexual abuse | Substance abuse
158
Mental illnesses exposing to eating disorders
Depression Anxiety (panic, agoraphobia) OCD
159
Gold std treatment in anorexia nervosa
Psychotherapy | Medication of little value
160
Admission of AN
< 65% standard body weight < 85% for adolescence Actively suicidal
161
Supplement for prevention of refeeding syndrom
Phosphorus
162
Admission for bulimia
If lytes abnormalities
163
Binge-eating disorder Tx
CBT
164
Bulimia Tx
SSRI | CBT
165
Onset of avoidant/restrictive foof intake disorder
Infancy
166
Eating disorder with Hx of GI conditions
Avoidant/restrictive
167
Avoidant/restrictive treatment
Psychoeducation Behavioral modification Psychotherapy
168
Important lytes in eating disorder
K Mg P
169
Mainstay of treatment of personality disorders
Psychotherapy
170
Personality disorders with familial association
Borderline Antisocial Schizotypal
171
Borderline with aging
Decreases
172
Borderline treatment
Dialectical behavioral therapy
173
Defense mechanism of borderline
Splitting
174
Defense mechanism of histrionic
Regression
175
Feeling of emptiness
Borderline
176
Age of Dx of antisocial
Symptoms present before age of 15 | Dx age 18
177
Lack of remorse
Antisocial
178
Disregard for safety
Antisocial
179
Lack of empathy
Narcissistic
180
Admiration seeking
Narciss
181
Attention seeking
Histrionic
182
Difficulty making decision
Dependent
183
Attachment style formation time
During 1st year
184
Personality establishment time
By adolescence or early adulthood
185
Best predictor of child’s attachment style
Caretaker’s attachment style
186
Normal separation anxiety
Between 10-18 mo
187
Child depression Tx
Psychotherapy | SSRI
188
1st line for children depression
Fluoxetine
189
2nd line for children depression
Escitalopram | Sertraline
190
Indications for ECT
``` Adolescents with: Severe depression Persistently suicidal Catatonic Psychotic ```
191
BP Tx in children
Mood stabilizer +/- antipsychotics Psychotherapy
192
Anxiety prognosis in children
Better with later onset
193
Eating disorder prognosis
Better with earlier onset
194
Anxiety Tx in children
Psychotherapy SSRI ( fluoxetine) Benzod If OCD, fluvoxamine, sertraline
195
Separation anxiety duration
4 wk
196
Common comorbidity associated with separation anxiety
MDD
197
Increased rate if remaining single
Social anxiety disorder
198
Child who often redoes tasks
GAD
199
Associated with Rett
Autism
200
Investigations for autism
``` Hearing test Vision test Intellectual functioning Learning Chrosomal analysis ```
201
Autism Tx
``` Team based Psychosocial Tx of concomitant disorders SGA (irritation, agitation, aggression, tics, self mutilation) SSRI (anxiety, depression) Stimulants ( inattention, hyperactivity) ```
202
Tx of tics in autism
SGA
203
Tx of self-mutilation in autism
SGA
204
Good prognosis in autism if
Early intervention IQ> 60 Able to communicate
205
Time of ADHD Dx
Onset before 12 y | Symptoms > 6 mo
206
Supplement for ADHD
Omega-3
207
ADHD Tx
1st line: stimulants +/- antidepressant +/- antipsychotics
208
2nd line for ADHD Tx
Atomoxetine
209
3rd line for ADHD Tx
Non-stimulants: a-agonists, clonidine, guanfacine, NDRI, bupropione)
210
Time for ODD Dx
6 mo | Onset < 8 y
211
ODD vs Conduct disorder
Absence of destructive or physically aggressive behavior in ODD
212
Tx of ODD
Parent psychoeducation Behavioral therapy School interventiobs Pharmacotherapy if comorbid disorders
213
Onset of conduct disorder
Before 10 y: childhood onset | After 10 y: adolescent onset, better prognosis
214
Tx of conduct disorder
Early intervention Psychosocial, CBT Pharmacotherapy for comorbid disorders
215
Poor prognosis Conduct disorder
``` Early age onset High frequency/variety of behaviors Pervasiveness Comorbid ADHD Early sexual activity Substance abuse ```
216
Age of diagnosis of intermittent explosive disorder
> 6 y
217
Indication of interpersonal psychotherapy
Mood disorder
218
Supportive psychotherapy
Adjustment disorder Psychosomatic Severe psychotic Personality disorder
219
Psychotherapy method for low insight individuals, low motivation, weak ego system
Supportive
220
Difficult to treat with behavioural psychotherapy
Personality disorders
221
Psychotherapy for conversion disorder
Psychoanalytic/Psychodynamic
222
Psychotherapy for personality disorders
Cognitive therapy
223
Psychotherapy for somatoform disorders
Cognitive therapy
224
Psychotherapy method requiring openness to changing core beliefs
Cognitive therapy
225
Psychotherapy using mindfulness
DBT
226
Psychotherapy for impulsivity
DBT
227
Psychotherapy for substance use
Motivational interviewing
228
Psychotherapy for obsessional thinking
Psychoanalytic/psychodynamic
229
Psychotherapy for sexual dysfunction
Psychoanalytic...
230
Response of thought disorder to antipsychotics
2-4 wk
231
Treatment refractory psychosis
Clozapine
232
No response to antipsychotic
Switch if no response after 4-6 wk
233
Minimum of antipsychotic therapy
6 mo
234
Acute psychosis management
Halopridol +/- lorazepam IM Loxapine +/- lorazepam Olanzapine Risperidone
235
Medications producing obsessive behavior
SGA
236
SGA with less weight gain
Risperidone Quetiapine Aripiprazole
237
SGA which may treat tardive symptoms
Clozapine
238
SGA with less risk of metabolic syndrome
Aripiprazole
239
SGA with highest risk of EPS
Risperidone
240
SGA with high risk of metabolic effects
Olanzapine | Clozapine
241
Most sedating SGA
Quetiapine
242
SGA with agranulocytosis
Clozapine
243
SGA with minimal anticholinergic effect
Olanzapine
244
Antipsychotics which warrant cardiac monitoring
Chlorpromazine Halopridol Clozapine Ziprasidone
245
Onset of acute dystonia
Within 5 days
246
Tx of acute dystonia
Benztropine | Diphenhydramine
247
Susceptible group to akathisia
Elderly female
248
Onset of acute akathesia
Within 10 days
249
Tx of acute akathesia
``` Lorazepam Propranolol Diphenhydramine Dose reduction Change to lower potency ```
250
Group susceptible to pseudoparkinsonism
Elderly females
251
Onset of pseudoparkinsonism
Within 30 days
252
Tx of pseudoparkinsonism
Benztropin Benzod Reduce dose Change to lower potency
253
Onset of dyskinasia
> 90 days
254
Tx of dyskinesia
None Try clozapine Drug D/C Dose reduction
255
Anantadine
Anticholinergic
256
Benztropine
Anticholinergic
257
Symptoms made worse by anticholinergics
Tardive syndromes
258
Antidepressant not needing taper
Fluoxetine
259
Relief of neurovegetative symptoms by antidepressants
1-3 wk
260
Relief of emotional/cognitive symptoms by antidepressants
2-6 wk
261
Time of increased risk of suicide by antidepressants
First 2 weeks
262
Antidepressants not prescribed for children
Paroxetine | Venlafaxine
263
Antidep with fewest drug interactions
Citalopram | Escitalopram
264
Sleep-wake neutral antidep
Citalopram | Escitalopram
265
Safest antidep in pregnancy and breastfeeding
Sertraline
266
Antideps for morning
Fluoxetine | Paroxetine
267
Sedating antidep
Fluvoxamine
268
Antidep with less sexual dysfunction
Bupropion
269
Antidep with risk of seizures
Bupropion
270
Antidep not recommended for anxiety
Bupropion
271
Antidep for seasonal depression
SSRI | BUPROPION
272
Antidep for PM
Fluvoxamine
273
Tx of coms due to TCA overdose
Physostigmine
274
Physostigmine
Acetylcholinesterase inhibitor
275
Phenelzine
MAOI
276
Antidep with less anticholinergic/antihistaminic effect
MAOI
277
Duloxetine
SNRI
278
Antidep with discontinuation syndrome
Paroxetine Venlafaxine Fluvoxamine
279
Onset/duration of antidep discontinuation syndrome
1-3 d | 1-3 wk
280
Tx of antidep discontinuation syndrome
Restart the same dose Taper over several weeks Use a drug with longer half-life
281
Alcohol withdrawal symptoms
``` Tremor Sweating Agitation Anorexia Cramps Diarrhea Sleep disturbance Seizures Hallucinations Delirium Autonomic hyperactivity (fever, tachycardia, HTN) ```
282
NMS symptoms
``` Develops over 24-72 h 1st: mental status change Fever Autonomic reactivity Rigidity Increased CPK, WBC Myoglobinuria ```
283
Serotonin syndrome
``` Nausea Diarrhea Palpitation Chills Restlessness Confusion Lethargy Myoclonus Hyperthermia Rigor Hypertonicity ```
284
Tx of serotonin syndrome
D/C | Emergency care
285
Tx of NMS
``` Supportive D/C Hydration Cooling blanket Dantrolene Bromocriptine ```
286
Antidep discontinuation syndrome
``` Anxiety Insomnia Irritability Mood lability Nausea/vomiting Dizziness Headache Dystonia Tremor Chills Fatigue Lethargy Myalgia Flu-like ```
287
Tests before mood stabilizers
CBC, U/A, BUN, Cr, lytes, TSH | ECG (if >45 yr or CVD risk)
288
Before Li
``` B-hCG TFT Seizure/neurologic Renal CVD ```
289
Full effect of mood stabilizers
2-4 wk
290
Acute mania
``` Li Li+ SGA Li+ lamotrigine Divalproex Divalproex+ SGA Carbamazepine ```
291
BP I depression
Li Li+ SSRI/Divalproex/bupropion Lamotrigine Divalproex + Li/SSRI
292
BP maintenance
``` Li Li+SGA Lamotrigine (+ Li for prevention of mania) Diva Diva+ SGA Carbamazepine Carba+ Li ```
293
Rapid cycling BPD
Divalproex | Carbamazepine
294
Li toxicity
``` N/V, diarrhea Cerebellar signs Drowsiness Myoclonus Tremor UMN signs Seizures Delirium Coma ```
295
Li toxicity Tx
``` D/C for several doses Check Li, BUN, lytes Begin again at a lower dose Saline infusion Hemodialysis if > mmol/L, coma, shock, severe dehydration, no response to Tx after 24 h, deterioration ```
296
Relative anxiolytics contraindications
MDD Hx of drug/alcohol Pregnancy/breastfeeding
297
High dose benzodiazepine withdrawal
Hyperpyrexia Seizures Psychosis Death
298
Withdrawal onset
1-2d (short-acting) | 2-4d (long-acting)
299
Withdrawal duration
Weeks-months
300
Benzod withdrawal management
Taper with long-acting benzod
301
Benzod antagonist
Flumazenil
302
Benzod with high dependency
Alorazolam
303
Memory loss resolution after ECT
6-9 mo
304
ECT contra
Increased ICP | within 2 weeks of MI
305
Aerobic exercise indications
MDD PTSD Schizo

Med (25 decks)

Brainscape helps you reach your goals faster, through stronger study habits.
© 2025 Bold Learning Solutions. Terms and Conditions